November 2025
164 articles-
-
-
Nov 30 · 07:54Biotechnology Daily
Reprogrammed poplar trees can make key industrial chemical for biodegradable plastics
-
Nov 30 · 07:54Bio Business News
AstraZeneca Plans $2 Billion Biomanufacturing Investment in Maryland
-
Nov 30 · 07:54Bio Business News
Metformin’s Surprising Potential Benefits in Type 1 Diabetes Therapy
-
-
Nov 29 · 04:29World News
New insight into how protein TDP-43 affects gene expression in ALS and FTD
-
Nov 29 · 04:29Biotechnology Daily
Artificial membranes mimic life-like dynamics through catalytic chemical reactions
-
Nov 29 · 04:28Biotechnology Daily
Watching DNA repair in real time with a live-cell sensor
-
Nov 29 · 04:28Bio Business News
Mapping the Neural Mechanism Behind Social Isolation Following Immune Challenge
-
Nov 29 · 04:28Bio Business News
Industry-Academia Collaboration Formed to Improve Cell and Gene Therapy Manufacturing
-
Nov 28 · 00:06World News
Specific brain activity patterns predict greater control over drinking behavior, study finds
-
Nov 28 · 00:06World News
Inhibiting a master regulator of aging regenerates joint cartilage in mice
-
Nov 28 · 00:06Biotechnology Daily
Drones: An ally in the sky to help save elephants
-
Nov 28 · 00:06Biotechnology Daily
RNA in action: Filming ribozyme self-assembly
-
Nov 28 · 00:06Bio Business News
Proteome-Wide AI Model Supports Rare Disease Diagnosis Using Evolution
-
Nov 28 · 00:06Bio Business News
Turbocharging Cas9’s Nuclear Entry
-
Nov 26 · 20:31World News
Grant funding disruptions affect one in 30 clinical trials
-
Nov 26 · 20:31World News
Monthly injection can help severe asthma patients safely stop or reduce daily steroids
-
Nov 26 · 20:31Biotechnology Daily
Scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
-
Nov 26 · 20:31Biotechnology Daily
Farms could be our secret climate weapon
-
Nov 26 · 20:31Bio Business News
Otsuka Secures IgAN Win as FDA Approves First Anti-APRIL Antibody
-
Nov 26 · 20:31Bio Business News
Novo’s GLP-1s Highlight List as CMS Unveils Final Prices For Second Cycle of Drug Negotiations
-
Nov 25 · 19:02World News
Myeloid mimicry enables kidney tumors to resist immunotherapy and worsen rapidly, study finds